1 文献来源rnChiorean EG,Cheung WY,Giordano G,et al. Real-world comparative effectiveness of nab-Paclitaxel plus Gemcitabine versus FOLFIRINOX in advanced pancre
1 文献来源rn研究一:Janssen QP ,Buettner S ,Suker M , et al. Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer:A systematic review
1 文献来源rnMiddleton G,Palmer DH,Greenhalf W,et al. Vandetanib plus Gemcitabine versus placebo plus Gemcitabine in locally advanced or metastatic pancreatic ca
1 文献来源rnConroy T, Hammel P, Hebbar M, et al. FOLFIRINOX or Gemcitabin as adjuvant therapy for pancreatic cancer[J]. N Eng J Med,2018,379(25):2395-2406.rn2